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Is there a need to redo many of the diagnoses of hypertension?
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aBStract
CONTEXT AND OBJECTIVE: Most hypertensive subjects undergoing treatment were diagnosed so-
lely through measurements made in the consultation office. The objective of this study was to redo 
the diagnosis of treated patients after new clinical measurements and ambulatory blood pressure 
monitoring (ABPM). 
DESIGN AND SETTING: Cross-sectional study conducted in an outpatient specialty clinic.
METHODS: Patients with mild-to-moderate hypertension or undergoing anti-hypertensive treatment, 
without target organ damage or diabetes, were included. After drug withdrawal lasting 2-3 weeks, new 
blood pressure (BP) measurements were made during two separate visits. ABPM was performed blindly, in 
relation to clinical measurements. The BP thresholds used for diagnosing hypertension, white-coat hyper-
tension, normotension and masked hypertension were: 140 (systolic) and 90 (diastolic) mmHg for office 
measurements and 135 (systolic) and 85 (diastolic) mmHg for mean awake ABPM (MAA). 
RESULTS: Evaluations were done on 101 subjects (70% women); mean age 51 ± 10 years. The clinical 
BP was 155 ± 18/97 ± 10 mmHg (first visit) and 150 ± 16/94 ± 11 mmHg (second visit); MAA was 137 ± 
13/ 86 ± 10 mmHg. Sixty-four patients (63%) were confirmed as hypertensive, 28 (28%) as white-coat 
hypertensive, nine (9%) as normotensive and none as masked hypertensive. After ABPM, 37% of the 
presumed hypertensive patients did not fit into this category. 
CONCLUSION: This study showed that hypertension was overdiagnosed among hypertensive subjects 
undergoing treatment. New diagnostic procedures should be performed after drug withdrawal, with the 
aid of BP monitoring. 
reSUMO
CONTEXTO E OBJETIVO: A maioria dos hipertensos em tratamento teve seu diagnóstico feito somente 
com medidas no consultório. O objetivo deste estudo é refazer o diagnóstico em pacientes tratados após 
novas medidas clínicas e monitorização ambulatorial da pressão arterial (MAPA).
TIPO DE ESTUDO E LOCAL: Estudo transversal realizado em clínica de especialidade.
MÉTODOS: Foram incluídos pacientes com hipertensão leve a moderada ou em tratamento anti-hiper-
tensivo, sem lesões de órgão-alvo ou diabetes. Após suspensão do tratamento por duas a três semanas, 
novas medidas da pressão arterial (PA) foram feitas em duas visitas distintas. A MAPA foi feita às cegas em 
relação às medidas clínicas. Os limites pressóricos utilizados para o diagnóstico da hipertensão, hiper-
tensão do avental branco, normotensão e hipertensão mascarada foram: 140 (sistólica) e 90 (diastólica) 
mmHg para as medidas de consultório e 135 (sistólica) e 85 (diastólica) mmHg para as médias de vigília 
da MAPA (MVM).
RESULTADOS: Foram avaliados 101 indivíduos (70% mulheres), idade 51 ± 10 anos. PA clínica: 155 ± 18/97 
± 10 mmHg (primeira visita) e 150 ± 16/94 ± 11 mmHg (segunda visita), MVM de 137 ± 13/86 ± 10 mmHg. 
Sessenta e quatro (63%) pacientes foram confirmados como hipertensos, 28 (28%) como portadores de 
hipertensão do “avental branco”, 9 (9%) como normotensos e nenhum como tendo hipertensão mascara-
da. Após a MAPA, 37% de presumíveis hipertensos não se enquadravam como tal.
CONCLUSÃO: Este estudo revela um excesso de diagnósticos de hipertensão em hipertensos tratados. 
Novos procedimentos diagnósticos devem ser realizados após suspensão da medicação, com auxílio das 
monitorizações da PA.
IMD, PhD. Head of the Blood Pressure 
Monitoring Service, Hypertensive Cardiopathy 
Clinic, Universidade Federal de São Paulo 
(Unifesp), São Paulo, Brazil.
IIMD, PhD. Full Professor of Cardiology, 
Hypertensive Cardiopathy Clinic, Universidade 
Federal de São Paulo (Unifesp), São Paulo, Brazil.
IIIMD, PhD. Cardiologist, Hypertensive 
Cardiopathy Clinic, Discipline of Cardiology, 
Universidade Federal de São Paulo (Unifesp), São 
Paulo, Brazil.
IVMD, PhD. Cardiologist and Adjunct Professor, 
Head of the Hypertensive Cardiopathy Clinic, 
Discipline of Cardiology, Universidade Federal 
de São Paulo (Unifesp), São Paulo, Brazil.
KEY WORDS:
Blood pressure determination.
Hypertension. 
Diagnostic techniques, cardiovascular. 
Blood pressure monitoring, ambulatory. 
Headache.
PALAVRAS-CHAVE:
Determinação da pressão arterial. 
Hipertensão.
Técnicas de diagnóstico cardiovascular. 
Monitorização ambulatorial da pressão arterial. 
Cefaléia.
Original article |Thalenberg JM, Luna Filho B , Bombig MTN, Francisco YA, Póvoa RMS
174     Sao Paulo Med J. 2012; 130(3):173-8
INTRODUCTION
The diagnosis of arterial hypertension (HT) is among the most 
commonly seen diagnoses in clinical practice and is one of the 
diagnoses most subject to error. Technical problems in blood pres-
sure (BP) measurements, low numbers of measurements made in 
consultation offices and the elevation of BP inherent to the med-
ical environment (“white coat” phenomenon) are frequent error 
factors.1 The advent of BP monitoring has cast new light on the 
diagnosis of HT through showing the differences that may exist 
between measurements in the office and outside of the office, 
whether made dynamically (ambulatory BP monitoring, ABPM) 
or statically (home BP monitoring, HBPM). Thus, such differences 
reveal the nuances that exist between established hypertension and 
normotension, and have even redefined these concepts. 
With regard to the new diagnostic categories created through 
monitoring, it has been seen that both diagnostic overestimation 
in the office (white coat hypertension, WCH) and underestimation 
(masked hypertension, MH) may have important consequences in 
clinical practice. Correct identification of these conditions is fun-
damental for avoiding unnecessary treatment (in WCH) or insti-
tuting adequate treatment (in MH).2 Proper attention must be 
given to the diagnosis of WCH in subjects with office hypertension, 
due to its high prevalence (15 to 30% of presumably hypertensive 
individuals).3 BP monitoring may also add prognostic value to the 
office measurements, with progressively higher cardiovascular risk 
until reaching maximum values when the three types of measure-
ment (office, ABPM and HBPM) are high.4
OBJECTIVE
Most individuals who are considered to be hypertensive are diag-
nosed and treated based only on office measurements. The aim 
of this study was to redo the diagnoses of clinically hypertensive 
subjects undergoing treatment after new office measurements 
and ambulatory blood pressure monitoring (ABPM). 
METHODS
In this cross-sectional study, 101 patients who had been referred to 
the Hypertensive Cardiopathy Sector of Universidade Federal de São 
Paulo (Unifesp) between March 2003 and March 2005 were assessed 
in screening consultations. The assessment consisted of a structured 
questionnaire and interpretation of the laboratory tests and electro-
cardiograms (EKG) that form part of the routine in this sector. The 
questionnaire included questions about: how long ago the hyper-
tension had been diagnosed; anti-hypertensive medications used 
(name and dose); other medications used; status of smoking and 
alcohol use; other ailments present; and hospital admissions (includ-
ing attendance for hypertensive crises). The inclusion criteria were 
that the subjects should be adults (age ≥ 18 years) with a register of 
systolic BP (SBP) ≥ 140 and < 180 mmHg or diastolic BP (DBP) ≥ 90 
and < 110 mmHg, or using antihypertensive medication. 
Patients were excluded if they presented: SBP ≥ 180 or DBP 
≥ 110 mmHg; a history of attendance for hypertensive crises 
of any origin; secondary hypertension; diabetes mellitus; atrial 
fibrillation; unstable or recent-onset angina; valvulopathy with 
functional class > 1; serum creatinine ≥ 1.5 mg/dl; body mass 
index ≥ 35; or Sokolow-Lyon index (SV1 + RV5/V6 ≥ 35 mm) 
on EKG.  Cases of moderate to severe chronic obstructive pul-
monary disease were also excluded because the patients were 
simultaneously participating in a study that included a respira-
tory test.5 Informed consent was obtained from all patients before 
their inclusion in the study, and the protocol had previously been 
approved by the institution’s Research Ethics Committee.
The antihypertensive medication of the patients selected was 
withdrawn for two to three weeks.6 Proper care was taken to avoid 
cases of rebound hypertension due to the withdrawal. Patients pre-
senting headache were given prior guidance regarding the absence 
of a causal relationship between primary hypertension and this 
symptom,7 and were told simply to take their usual analgesics and/
or anti-migraine drugs for the duration of the suspension of the anti-
hypertensive medication. A contact telephone number was provided 
in case any patients had queries during the suspension period. 
When the patients came back to the consultation office, BP 
was determined using a mercury sphygmomanometer (Wan 
Med, São Paulo, Brazil) graduated every 2 mm, with cuffs of ade-
quate size for the upper arm circumference. BP was measured in 
both arms with the patient seated, and the arm with the higher 
BP was chosen. After waiting for two minutes, another measure-
ment was made in the same arm. If the DBP differed by more 
than 5 mmHg, the procedure was repeated until measurements 
with a smaller difference were obtained.
The patient was then immediately fitted with a monitor in 
order to perform 24-hour ABPM (Dyna-MAPA, Cardios Siste-
mas, São Paulo, Brazil; equivalent to Mobil-O-Graph, I.E.M., 
Stolberg, Germany), with an appropriate cuff placed on the non-
dominant arm. The device was programmed to measure BP every 
15 minutes while the patient was awake and every 30 minutes 
while asleep. The times of going to sleep and waking up were 
established individually and checked using diary records. 
On the next day, after the monitor had been removed, the 
same procedures as described above were performed to measure 
BP at a new consultation. The ABPM results were interpreted in 
a blinded manner in relation to the clinical measurements, and 
were interpreted in accordance with the Brazilian guidelines.8 
We considered that records consisting of at least 50 BP measure-
ments taken while the patient was awake were valid.
The clinical measurements were made by a trained physician, 
who performed them without any observer admitted during 
the procedure, in order to avoid raising the patient’s BP.9 All the 
clinical measurements were obtained in the mornings, between 
11:00 a.m. and 12:00 noon.
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The following diagnostic criteria were used: Hypertension 
(HT), if the clinical BP was ≥ 140 (systolic) or 90 (diastolic) mmHg 
at both medication-free consultations (also in the screening, if 
the patient had not been under medication) and the mean ABPM 
while awake was ≥ 135 (systolic) or 85 (diastolic) mmHg; white 
coat hypertension (WCH) if the clinical measurements were as 
above, and the mean ABPM while awake was < 135/85  mmHg; 
masked hypertension (MH) if the clinical BP was < 140/90 mmHg 
at both consultations or at the second consultation, and the mean 
ABPM while awake was ≥ 135 (systolic) or 85 (diastolic) mmHg; 
normotension (NT) if the clinical BP was as above and the mean 
ABPM while awake was < 135/85 mmHg.
Considering a mean prevalence of 20% WCH, alpha error of 
5% and statistical power of the sample of 90%, we estimated that it 
would be necessary to have 92 individuals with a presumed diag-
nosis of sustained hypertension. The results were expressed as 
means and standard deviations (SD). Proportions were expressed 
as percentages. We used the Microsoft Excel software to calculate 
the means and SD.
RESULTS
The participants in this study comprised 71 women and 30 men, 
with a mean age of 50.7 ± 10 years. Of these, 57 patients were 
white, 40 were black and four were East Asian. Ten patients (seven 
women) were over the age of 65 years. Ninety-four patients were 
regularly using antihypertensive medication: 17 using mono-
therapy, 74 using two drugs and three using three drugs (these 
last three at sub-optimal doses). The drugs used belonged to the 
following categories: thiazide diuretics, beta-blockers, dihydro-
pyridine calcium channel blockers and angiotensin-converting 
enzyme inhibitors. All of these were available through the public 
healthcare system of the city of São Paulo. 
The mean BP measurements in the consultation office were: 
155 ± 18/97 ± 10 mmHg at the first visit and 150 ± 16/94 ± 11 
mmHg at the second visit. The mean ABPM while awake was 137 
± 13/86 ± 10 mmHg. 
Nine patients (9%) presented normal clinical BP and ABPM 
measurements, even after withdrawal of the medication. Six-
ty-four patients (63%) were classified as HT and 28 (28%) as 
WCH. None of the patients was classified as MH. Among the 
seven patients who were not using medications at the time of 
the screening, five of them were classified as HT after ABPM and 
two, as WCH. After the ABPM, 37% of the supposed hypertensive 
patients were found not to fit into this category. Figure 1 shows 
the diagnostic algorithm for the study and its results. Table 1 
shows the mean BP according to diagnostic category.
The telephone number that was made available for con-
tacts in the event of queries during the medication suspension 
period was only used by two female patients, who both presented 
chronic headache. They presented pain episodes that were similar 
Triage
BP < 180/110 mm Hg
and ≥ 140/90 if not medicated
No previous hypertensive crises
No TOD
No diabetes
BMI < 35 kg/m2
Drug withdrawal
2 to 3 weeks
BP < 140/90
n = 5
BP ≥ 140/90
n = 0
BP < 140/90
n = 5
BP < 140/90
n = 4
BP > 140/90
n = 96
BP > 140/90
n = 92
BP < 135/85
n = 9
BP ≥ 135/85
n = 0
BP < 135/85
n = 28
BP ≥ 135/85
n = 64
n = 9
n = 101
Visit 1 Visit 2  Mean awake ABPM Diagnosis (%)
HT (63%)
WCH (28%)
MH (0)
NT (9%)
BP = blood pressure, all values presented in mmHg; TOD = target organ damage; ABPM = ambulatory blood pressure monitoring; 
HT = hypertension; NT = normotension; BMI = body mass index; MH = masked hypertension; WCH = white coat hypertension.
Figure 1. Diagnostic algorithm and results.
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to those that had been experienced while under antihypertensive 
treatment. They were advised again to only take the analgesics 
that they were already using regularly, and they came back to the 
office without intercurrences, to continue with the protocol. A 
third female patient went through a similar situation, did not get 
in touch and dropped out of the study.
DISCUSSION
In this study, hypertensive individuals’ diagnoses were redone 
after their medication had been withdrawn, with new measure-
ments at two consultations in the office and through ABPM. At 
the end of this procedure, 37% of these individuals were found 
not to fit into the initial diagnostic category. This result suggests 
that hypertension is being diagnosed excessively, with possible 
clinical and economic consequences for the population and for 
the healthcare system.
Variations in blood pressure are a challenge with regard to 
clinical diagnosis and hypertension control. The spontaneous fall 
in BP between the first and second consultations (Table 1) was 
probably due to attenuation of the patients’ alert reaction to the 
medical environment. This attenuation occurs through repeated 
visits (habituation effect). This confirms that there is a need to have 
at least two consultations after screening, in order to make clinical 
diagnoses of hypertension.10,11 Through this procedure, we found 
that nine patients presented normal BP (9% of the initial sample): 
all of them had previously been taking antihypertensive medica-
tion without showing any symptoms suggestive of hypotension. 
WCH seems to be a conditioned response to the medical 
environment that does not disappear with time.12 There is no 
need for antihypertensive medication, except in cases of elevated 
cardiovascular risk. It is possibly a pre-hypertensive state,13,14 
which therefore requires control more frequently than for nor-
motensive individuals. For WCH to be diagnosed, monitoring 
outside of the office is essential. In our study, 28% of the sample 
was shown to have this condition after ABPM. This result cor-
roborates the affirmation of the European Hypertension Society: 
“In truth, it must be admitted that it is difficult to escape the con-
clusion that all patients in whom a diagnosis of hypertension is 
being contemplated based on office/clinic BP, should have ABPM 
to exclude WCH”.15 Home BP monitoring (HBPM) may also be 
used for this same purpose.16 
We did not detect any cases of masked hypertension. This is a 
condition that is generally investigated in supposedly normotensive 
individuals who present target organ damage. Our result was not 
surprising, given that we were only analyzing individuals who were 
supposedly hypertensive and did not have target organ damage, in 
accordance with the exclusion criteria adopted. Masked hyperten-
sion carries a cardiovascular risk that is close to that of sustained 
hypertension, and should be treated in the same way.17
Withdrawal of the antihypertensive medication is the funda-
mental measure for redoing the diagnosis, since in such cases, 
the medication treatment acts as a confounding factor. This is an 
ethical and safe procedure among hypertensive individuals with-
out complications, provided that the due precautions are taken in 
relation to drugs that, if withdrawn, may cause rebound hyper-
tension, such as clonidine.18 All of the patients accepted the pro-
posed withdrawal well, after being given proper explanations. 
With regard to the three patients who were using regimens of 
three medications belonging to different classes, none of them 
fitted into the category of resistant hypertension according to the 
criterion of the doses used (for example, patient no. 55 was using 
the following daily doses: hydrochlorothiazide 25 mg, captopril 
50 mg and propranolol 40 mg). In our study, all the patients had 
their medication withdrawn only once. As expected, no cases of 
rebound hypertension occurred during the suspension period.
The greater number of women in the sample reflects the 
frequencies of users of the Hypertensive Cardiopathy Sector 
(women to men, 7:3). This was not a surprise to us, since in Bra-
zil, women seek healthcare services more than men do.19 The 
diagnosis of WCH is of great importance among women, given 
that they are more susceptible to this condition.20 WCH was 
found in 35% of the women and 20% of the men in our sample, 
after excluding the nine normotensive patients. 
There is often an association between headache and 
hypertension,21 since these are both highly prevalent conditions 
worldwide. Nonetheless, several studied using ABPM and/or 
clinical measurements have suggested that there is no causal rela-
tionship between these two conditions.22-27 In a recent prospective 
study on a large population, it was even found that there was an 
inverse relationship between headache and blood pressure levels, 
and it was suggested that this was related to the phenomenon of 
hypertension-associated hypalgesia.28,29 Primary hypertension is 
only a proven cause of headache in cases of hypertensive enceph-
alopathy, a hypertensive emergency in which cerebral edema is 
associated. The myth of hypertension as a cause of headache may 
contribute towards lowering the adherence to antihypertensive 
Visit 1 Visit 2 Mean awake ambulatory blood pressure monitoring
Hypertension 158 ± 18/101 ± 10 154 ± 16/99 ± 10 144 ± 10/91 ± 8
White coat hypertension 150 ± 13/92 ± 8 146 ± 11/89 ± 9 125 ± 6/77 ± 6 
Normotension 141 ± 20/87 ± 10 130 ± 8/81 ± 7 124 ± 6/74 ± 5
Table 1. Mean blood pressure (BP) in mmHg according to diagnostic category
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treatment, if absence of pain is taken by patients to be an indi-
cator of controlled hypertension. In the present study, this clari-
fication was provided to the patients with headache and was an 
important part of the screening consultation.
Our study found that 9% of the patients were normoten-
sive, which was an unexpected find among hypertensive patients 
undergoing treatment at a reference center for hypertension. This 
suggests that the initial clinical diagnosis had not been made with 
the due care, such that the patient was referred to the specialized 
service already under medication and was accepted by this ser-
vice as hypertensive. In our sample, after withdrawal of the med-
ication, four of these patients were found to have normal BP at 
the second consultation and five of them, at both consultations. If 
these individuals had not had their diagnoses redone, they would 
have been considered to be hypertensive patients and would have 
continued to undergo treatment, if only because they did not 
present any symptoms of hypotension when under medication.
Correctly diagnosed hypertension is an absolute necessity for 
any healthcare system. The financial cost of unduly treating cases of 
WCH may be high. In a study conducted on 255 hypertensive indi-
viduals, it was seen after ABPM that 21% had WCH. If only the true 
hypertensive individuals had been treated, this would have resulted 
in savings that this study estimated to be US$ 110,000 over a six-year 
period.30 In another study with a sample of 62 hypertensive patients, 
of whom 26% were found to present WCH after ABPM, the financial 
cost of using this method started to be recompensed from the third 
year of use onwards.31 This is something to be taken into account in 
relation to a highly prevalent disease for which the treatment is life-
long. So far, there have not been any studies evaluating the costs of 
the possible iatrogenic hypotensive effects induced by improper or 
excessive use of antihypertensive medication, such as falls and epi-
sodes of myocardial ischemia in coronary disease patients.
CONCLUSIONS
In conclusion, the present study detected a high prevalence of 
non-hypertensive individuals among presumed clinically hyper-
tensive outpatients undergoing treatment, who were all non-
diabetic and did not present target organ damage. This finding 
indicates that there is a need to redo the diagnosis among hyper-
tensive individuals with this profile, with the aid of out-of office 
BP monitoring.
This study also suggests that, in relation to the inclusion crite-
ria for clinical trials, individuals whose diagnosis of hypertension 
was made only with office measurements should not be taken a 
priori to be true hypertensive subjects, just because they are using 
antihypertensive medication.
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